ArticlePloS one2025
Calculating age-specific prevalence rates of female genital mutilation / cutting (FGM/C) for use as an input variable in extrapolation calculations and as predictors of future prevalence in countries of origin.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This paper proposes a refined method for calculating age-specific prevalence rates of Female Genital Mutilation/Cutting (FGM/C) to enhance the accuracy of estimates calculated using Yoder and Van Baelen's Extrapolation-of-FGM/C-Countries-Prevalence-Data method. Previous studies, particularly in the United States, have faced limitations, including the failure to disaggregate prevalence data by age and overlooking historical trends. To address these limitations, this study outlines a comprehensive seven-step approach. Using Ethiopia as a case study, prevalence rates were calculated and aligned with target migrant population data. This involved adjusting age cohorts, extrapolating prevalence to younger age groups, and considering historical trends. Results demonstrate significant differences compared to previous estimates, indicating overestimation of girls at risk of FGM/C in some studies. The proposed method offers a standardized approach applicable beyond the United States, potentially improving estimates globally. By providing nuanced prevalence data, this method contributes to better understanding the true prevalence of FGM/C in migrant populations. This same method can also be used to predict future trends in FGM/C and other practices.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.